Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

December 21, 2016

Primary Completion Date

March 22, 2018

Study Completion Date

March 22, 2018

Conditions
Atrial Fibrillation
Interventions
BEHAVIORAL

Mobile Application Intervention

Mobile phone application that sends reminders and allows participants to self-manage their medication adherence. Monitoring of participant adherence from this tool will be performed by the central coordinating center, which will send notifications or contact the participant based on the adherence history in accordance with the study protocol.

OTHER

No Intervention

Participants will receive physician- or nurse-guided standard of care.

Trial Locations (25)

Unknown

Anchorage

Los Angeles

Manhattan Beach

Oakland

Pasadena

Stanford

Ventura

Pensacola

Overland Park

Lexington

Saint Joseph

Reno

Buffalo

Jamaica

Lake Success

Mineola

Saratoga Springs

Canton

Doylestown

Reading

Yardley

Memphis

Nashville

Austin

Bellevue

All Listed Sponsors
lead

Janssen Scientific Affairs, LLC

INDUSTRY

NCT02996435 - Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation | Biotech Hunter | Biotech Hunter